Thompson Rahsaan bought ZVRA
January 29, 2026 · Form 4 insider transaction
Thompson Rahsaan bought 37,500 shares of Zevra Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
37,500
Price
$0.00
Total value
N/A
InsiderThompson Rahsaan
Role—
SecurityRestricted Stock Unit
Transaction codeA: Grant or award
Transaction dateJanuary 29, 2026
Filing dateFebruary 2, 2026
Shares owned after37,500
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.; The restricted stock units will vest and settle as to one third of the restricted stock units on January 29, 2027, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting Person's continued service through such vesting date.